PRGO:NYSE
Perrigo Company PLC
11,85 US$
arrow_downward
-0,59%(-0,070) 1K
4-may, 10:16:32 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoPRGO tikeri uchun statistika yaratilmoqda...
Ochish
11,89 US$
Yuqori
11,94 US$
Past
11,77 US$
Bozor kapitali
1,63 mlrd
Hajmi
72,28 ming
Dividend
9,79%
Choraklik dividendlar
0,29 US$
Eks-dividend sanasi
29-may, 2026
52 haftalik eng yuqori
28,44 US$
52 haftalik eng past
9,23 US$
Aksiya boʻyicha daromad
-10,12 US$
Beta
0,50
Muomaladagi aksiyalar
137,65 mln
Xodimlar soni
8 ming
Yangiliklar
Internetdagi manbalardan
Profil
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Perrigo Company PLC haqida
AI kontentda xatolar boʻlishi mumkin. Batafsil